Although the PD-1 inhibitor showed a slight trend of improving the DCR when compared with control arms, the result was not significant with an RR of 1.15 (95% CI 0.91 to1.45, P = 0.25) (Figure 3B ).
← all excerpts
Effectiveness and safety of PD-1/PD-L1 inhibitors in the treatment of solid tumors: a systematic review and meta-analysis.
1
—
—